We are live on ! Find out more
SC

SummitTX Capital Portfolio holdings

AUM $3.2B
1-Year Est. Return 41.22%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+41.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.32B
AUM Growth
+$896M
Cap. Flow
+$807M
Cap. Flow %
24.32%
Top 10 Hldgs %
28.1%
Holding
1,021
New
296
Increased
249
Reduced
128
Closed
348

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$24.9M
2
FYBR
Frontier Communications
FYBR
+$17.5M
3
CAT icon
Caterpillar
CAT
+$15.2M
4
DTE icon
DTE Energy
DTE
+$15M
5
FTI icon
TechnipFMC
FTI
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 13.67%
2 Industrials 13.31%
3 Healthcare 11.55%
4 Consumer Discretionary 6.78%
5 Real Estate 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
251
ExxonMobil
XOM
$644B
$2.8M 0.08%
23,290
+14,205
+156% +$1.65M
HRB icon
252
H&R Block
HRB
$5.58B
$2.8M 0.08%
64,209
+28,121
+78% +$1.31M
H icon
253
Hyatt Hotels
H
$16.4B
$2.74M 0.08%
17,109
-29
-0.2% -$4.44K
IMNM icon
254
Immunome
IMNM
$2.58B
$2.74M 0.08%
+127,613
New +$2.24M
GL icon
255
Globe Life
GL
$14.2B
$2.74M 0.08%
19,578
+14,190
+263% +$1.92M
BBIO icon
256
BridgeBio Pharma
BBIO
$15.7B
$2.74M 0.08%
35,785
-1,426
-4% -$93.6K
CBRL icon
257
Cracker Barrel
CBRL
$1.26B
$2.73M 0.08%
107,626
+90,434
+526% +$2.89M
BMY icon
258
Bristol-Myers Squibb
BMY
$133B
$2.73M 0.08%
50,573
-5,249
-9% -$253K
MO icon
259
Altria Group
MO
$114B
$2.71M 0.08%
+47,070
New +$2.84M
GH icon
260
Guardant Health
GH
$21.7B
$2.69M 0.08%
+26,295
New +$2.35M
CFLT
261
DELISTED
Confluent
CFLT
$2.68M 0.08%
+88,501
New +$2.17M
SN icon
262
SharkNinja
SN
$22.9B
$2.66M 0.08%
23,760
+19,909
+517% +$1.96M
AMLX icon
263
Amylyx Pharmaceuticals
AMLX
$2.26B
$2.64M 0.08%
218,399
+50,399
+30% +$685K
EXPE icon
264
Expedia Group
EXPE
$35.4B
$2.64M 0.08%
+9,301
New +$2.3M
FR icon
265
First Industrial Realty Trust
FR
$8.73B
$2.62M 0.08%
+45,714
New +$2.55M
ISRG icon
266
Intuitive Surgical
ISRG
$127B
$2.62M 0.08%
4,621
-1,946
-30% -$1.04M
CRL icon
267
Charles River Laboratories
CRL
$11.2B
$2.61M 0.08%
+13,066
New +$2.37M
BF.B icon
268
Brown-Forman Class B
BF.B
$13.2B
$2.58M 0.08%
99,102
+5,577
+6% +$157K
MAR icon
269
Marriott International
MAR
$98.3B
$2.57M 0.08%
+8,272
New +$2.36M
BBY icon
270
Best Buy
BBY
$18.2B
$2.55M 0.08%
38,030
-7,200
-16% -$549K
CAG icon
271
Conagra Brands
CAG
$6.94B
$2.52M 0.08%
145,579
+68,340
+88% +$1.21M
ESTA icon
272
Establishment Labs
ESTA
$2.72B
$2.52M 0.08%
+34,567
New +$2.09M
GO icon
273
Grocery Outlet
GO
$909M
$2.5M 0.08%
+247,671
New +$3.12M
DNN icon
274
Denison Mines
DNN
$2.54B
$2.49M 0.08%
937,858
-936,800
-50% -$2.55M
LNC icon
275
Lincoln National
LNC
$8.73B
$2.48M 0.07%
55,805
+40,937
+275% +$1.71M

Similar funds

SummitTX Capital's Q4 2025 Portfolio in Review

As of Q4 2025, SummitTX Capital held 1,021 positions worth $3.32B, up 37% from $2.42B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

SummitTX Capital deployed $807M of net new capital in Q4 2025, opening 296 new positions and adding to 249 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 299,442 shares worth $57.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Teradyne, an estimated $24.9M trimmed.

  • SummitTX Capital's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 299,442 shares worth $57.4M.
  • SummitTX Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $185M increase.
  • SummitTX Capital's biggest Q4 2025 reduction was Teradyne, cutting an estimated $24.9M.
  • SummitTX Capital fully exited Caterpillar in Q4 2025, selling an estimated $15.2M.
  • SummitTX Capital's ten largest holdings make up 28% of its $3.32B portfolio in Q4 2025.
  • SummitTX Capital opened 296 new positions and closed 348 in Q4 2025.
  • SummitTX Capital's portfolio value rose 37% quarter-over-quarter to $3.32B.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.